The RNFT2/IL-3Rα axis regulates IL-3 signaling and innate immunity
Authors:
- Yao TongYTYao Tong
- Travis B. LearTLTravis B. Lear
- John EvankovichJEJohn Evankovich
- Yanwen ChenYCYanwen Chen
- James D. LondinoJLJames D. Londino
- Michael M. MyerburgMMMichael M. Myerburg
- Yingze ZhangYZYingze Zhang
- Iulia D. PopescuIPIulia D. Popescu
- John F. McDyerJMJohn F. McDyer
- Bryan J. McVerryBMBryan J. McVerry
- Karina C. LockwoodKLKarina C. Lockwood
- Michael J. JurczakMJMichael J. Jurczak
- 13 February 2020
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 5 (3)
Abstract
Interleukin-3 (IL-3) receptor α (IL-3Rα) is the α subunit of the ligand-specific IL-3R and initiates intracellular signaling in response to IL-3. IL-3 amplifies proinflammatory signaling and cytokine storm in murine sepsis models. Here we found that RNFT2 (RING finger transmembrane-domain containing protein 2, also TMEM118), a previously uncharacterized RING finger ubiquitin E3 ligase, negatively regulated IL-3–dependent cellular responses through IL-3Rα ubiquitination and degradation in the proteasome. In vitro, IL-3 stimulation promoted IL-3Rα proteasomal degradation dependent on RNFT2, and we identified IL-3Rα lysine 357 as a ubiquitin acceptor site. We determined that LPS priming reduces RNFT2 abundance, extends IL-3Rα half-life, and sensitizes cells to the effects of IL-3, acting synergistically to increase proinflammatory signaling. In vivo, IL-3 synergized with LPS to exacerbate lung inflammation in LPS and Pseudomonas aeruginosa –challenged mice; conversely, IL-3 neutralization reduced LPS-induced lung injury. Further, RNFT2 overexpression reduced lung inflammation and injury, whereas Rnft2 knockdown exacerbated inflammatory responses in LPS-induced murine lung injury. Last, we examined RNFT2 and IL-3Rα in human lung explants from patients with cystic fibrosis and also showed that IL-3 is elevated in mechanically ventilated critically ill humans at risk for acute respiratory distress syndrome. These results identify RNFT2 as a negative regulator of IL-3Rα and show a potential role for the RNFT2/IL-3Rα/IL-3 axis in regulating innate immune responses in the lung.Keywords
Funding Information
- National Institutes of Health (HL139860)
- National Institutes of Health (P50AR060780)
- National Institutes of Health (HL133184)
- National Institutes of Health (HL143843)
- National Institutes of Health (HL144820)
- American Heart Association (16SDG27650008)
- National Institutes of Health (HL14277)
- National Institutes of Health (DK072506)
- National Institutes of Health (HL114453)
This publication has 57 references indexed in Scilit:
- A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammationNature Immunology, 2013
- The GM–CSF/IL‐3/IL‐5 cytokine receptor family: from ligand recognition to initiation of signalingImmunological Reviews, 2012
- The Ubiquitin CodeAnnual Review of Biochemistry, 2012
- F-box protein FBXL19–mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammationNature Immunology, 2012
- Stimulation of Rho signaling by pathologic mechanical stretch is a “second hit” to Rho-independent lung injury induced by IL-6American Journal of Physiology-Lung Cellular and Molecular Physiology, 2012
- HECT and RING finger families of E3 ubiquitin ligases at a glanceJournal of Cell Science, 2012
- A Novel TNF Receptor-Associated Factor 6 Binding Domain Mediates NF-κB Signaling by the Common Cytokine Receptor β SubunitThe Journal of Immunology, 2010
- Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine productionNature Immunology, 2009
- Diversity of degradation signals in the ubiquitin–proteasome systemNature Reviews Molecular Cell Biology, 2008
- Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6Nature, 2005